1. Home
  2. RFL vs JMM Comparison

RFL vs JMM Comparison

Compare RFL & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • JMM
  • Stock Information
  • Founded
  • RFL 2017
  • JMM 1988
  • Country
  • RFL United States
  • JMM United States
  • Employees
  • RFL N/A
  • JMM N/A
  • Industry
  • RFL Real Estate
  • JMM Trusts Except Educational Religious and Charitable
  • Sector
  • RFL Finance
  • JMM Finance
  • Exchange
  • RFL Nasdaq
  • JMM Nasdaq
  • Market Cap
  • RFL 60.7M
  • JMM 58.6M
  • IPO Year
  • RFL N/A
  • JMM N/A
  • Fundamental
  • Price
  • RFL $1.90
  • JMM $6.23
  • Analyst Decision
  • RFL
  • JMM
  • Analyst Count
  • RFL 0
  • JMM 0
  • Target Price
  • RFL N/A
  • JMM N/A
  • AVG Volume (30 Days)
  • RFL 440.7K
  • JMM 16.1K
  • Earning Date
  • RFL 06-11-2025
  • JMM 01-01-0001
  • Dividend Yield
  • RFL N/A
  • JMM 5.44%
  • EPS Growth
  • RFL N/A
  • JMM N/A
  • EPS
  • RFL N/A
  • JMM N/A
  • Revenue
  • RFL $732,000.00
  • JMM N/A
  • Revenue This Year
  • RFL N/A
  • JMM N/A
  • Revenue Next Year
  • RFL N/A
  • JMM N/A
  • P/E Ratio
  • RFL N/A
  • JMM N/A
  • Revenue Growth
  • RFL 35.56
  • JMM N/A
  • 52 Week Low
  • RFL $1.27
  • JMM $5.29
  • 52 Week High
  • RFL $3.19
  • JMM $6.10
  • Technical
  • Relative Strength Index (RSI)
  • RFL 53.05
  • JMM 50.20
  • Support Level
  • RFL $1.81
  • JMM $6.22
  • Resistance Level
  • RFL $2.04
  • JMM $6.41
  • Average True Range (ATR)
  • RFL 0.16
  • JMM 0.10
  • MACD
  • RFL 0.00
  • JMM -0.00
  • Stochastic Oscillator
  • RFL 71.43
  • JMM 42.55

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

Share on Social Networks: